Yann Le Cam of EURORDIS on EU rare disease treatment at World Orphan Drug Congress USA

RE(ACT) Congress 2014 - Yann Le Cam, EURORDISПодробнее

NIH, EURORDIS and more on globalizing orphan drug access at World Orphan Drug Congress USA 2013Подробнее

Yann Le Cam sets the case for a new European framework for rare diseasesПодробнее

An EU single orphan drug market with SOBI, EURORDIS and more at World Orphan Drug Congress USA 2013Подробнее

Yann le Cam - (Part 1) Concluding remarks from European Workshop on Rare Disease ResearchПодробнее

#ECRD2020 Yann Le Cam, on what will be different by 2030Подробнее

Rare disease and orphan drugs: industry executives at World Orphan Drug Congress USAПодробнее

Speech (part 1) by Yann le Cam EURORDIS - Rare Disease Day 2009Подробнее

Rare Disease Day 2014 message from Yann Le CamПодробнее

Speech (part 2) by Yann le Cam EURORDIS - Rare Disease Day 2009Подробнее

The World Orphan Drug CongressПодробнее

Angus Russell of Shire on social responsibility in rare diseases at World Orphan Drug Congress USAПодробнее

Anne Pariser of the FDA on natural history studies in rare disease at World Orphan Drug Congress USAПодробнее

Rare Disease Day "Join Together for Better Care"Подробнее

Yann le Cam - (Part 3) Concluding remarks from European Workshop on Rare Disease ResearchПодробнее

Yann le Cam - (Part 2) Concluding remarks from European Workshop on Rare Disease ResearchПодробнее

5th EURORDIS survey on access to Orphan Drugs in EuropeПодробнее

Orphan drug discoveries & academic centers of excellence at World Orphan Drug Congress USAПодробнее